Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists.

by Nienke van Rein, Willem M Lijfering, Mettine H A Bos, Martien H Herruer, Helga W Vermaas, Felix J M van der Meer, Pieter H Reitsma
Published 2016-01-01

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

by Myrthe M. A. Toorop, Nienke vanRein, Melchior C. Nierman, Helga W. Vermaas, Menno V. Huisman, Felix J. M. van derMeer, Suzanne C. Cannegieter, Willem M. Lijfering
Published 2020-05-01

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

by Gilda Denise Zielinski, Nienke vanRein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van derMeer, Menno V. Huisman, Suzanne C. Cannegieter, Willem M. Lijfering
Published 2020-01-01

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.

by Judith Kooiman, Nadja van Hagen, Antonio Iglesias Del Sol, Erwin V Planken, Gregory Y H Lip, Felix J M van der Meer, Suzanne C Cannegieter, Frederikus A Klok, Menno V Huisman
Published 2015-01-01

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.

by Gudula J A M Boon, Nienke van Rein, Harm Jan Bogaard, Yvonne M Ende-Verhaar, Menno V Huisman, Lucia J M Kroft, Felix J M van der Meer, Lilian J Meijboom, Petr Symersky, Anton Vonk Noordegraaf, Frederikus A Klok
Published 2020-01-01

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.

by Gudula J A M Boon, Nienke van Rein, Harm Jan Bogaard, Yvonne M Ende-Verhaar, Menno V Huisman, Lucia J M Kroft, Felix J M van der Meer, Lilian J Meijboom, Petr Symersky, Anton Vonk Noordegraaf, Frederikus A Klok
Published 2020-01-01